Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
NCT: NCT06921148 · RECRUITING
NCT IDNCT06921148
StatusRECRUITING
Start Date2025-04-30
Completion2028-06-14
SponsorIndiana University (OTHER)
First posted
Last updated
Brief Summary
This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.
Frequently Asked Questions
What is Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy?
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy is a clinical trial registered under NCT06921148. Current status: RECRUITING.
What is the status of NCT06921148?
The current status of NCT06921148 (Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy) is: RECRUITING.
When did Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy start?
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy started on 2025-04-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.